Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

AHRQ fact sheet aligns providers to National Quality Strategy

The Agency for Healthcare Research and Quality has published a new fact sheet to align providers to the National Quality Strategy.

Industry asks for legislation advancing patient data sharing

Medical industry executives told Congress that they would like to see more legislation allowing sharing of patient data, but legislators expressed reservations about unauthorized access to protected patient information, reported The Hill.

Thumbnail

5 take-aways from latest congressional hearing on Medicare fraud

On Wednesday, representatives of the Department of Health and Human Services (HHS), the Centers for Medicare and Medicaid Services (CMS) and the Government Accountability Office (GAO) were once again called upon by House republicans to explain what is being done to combat waste, fraud and abuse in Medicare. Their responses give a glimpse into the agencies current priorities, especially as they affect healthcare providers.

Thumbnail

Is your clinical lab sending you illegal kickbacks?

A new Office of Inspector General (OIG) fraud alert warns of two arrangements with clinical laboratories that it considers illegal kickbacks for referrals — specimen processing arrangements and registry arrangements — that are subtle enough that not all ordering physicians who receive the payments may be aware that they are breaking the law.

Struggling hospitals investing less in analytics, population health

Financial system transformation is taking center stage as a hospital technology priority as healthcare executives look to remain financially solvent. As such, many struggling hospitals are putting population health and analytics on the back burner, according to a survey from Black Book.

Thumbnail

Time to Reassess MU

Some of us have been publicly calling for relief in the timelines of the Meaningful Use program since it was created by ARRA in 2009. The recently proposed program changes are thus welcome.  Do they go far enough?

Thumbnail

HFMA survey: Strategy now beats competitive advantage as reason to merge

The pressure to control costs and manage risk-based payment systems is changing the reasons why healthcare providers merge finds a new survey of Healthcare Financial Management Association (HFMA) members.

Thumbnail

4 factors expected to increase healthcare sector growth in 2015

For 2015, the PricewaterhouseCoopers (PwC) Health Research Institute (HRI) is forecasting an end to the five-year contraction in the $2.8 trillion health industry. It predicts medical cost growth of 6.8 percent, up from the 6.5 percent it projected for 2014.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.